What is creatine?
The NIH describes creatine as a compound that helps supply muscles with energy, particularly for short-term, predominantly anaerobic activity.
Creatine monohydrate is one of the most studied ingredients in sports nutrition. This page explains the ingredient generally and keeps that evidence separate from claims about the finished TARRU gummy.
The NIH describes creatine as a compound that helps supply muscles with energy, particularly for short-term, predominantly anaerobic activity.
The NIH identifies creatine monohydrate as the most widely used and studied form of creatine in supplements.
The NIH summarizes numerous trials showing benefits for repeated, high-intensity intermittent activity, with individual response varying.
The NIH fact sheet says creatine has been extensively studied and may improve strength, power, and work from maximal-effort muscle contractions. It also notes that responses vary and that creatine is of little value for endurance sports.
Read NIH sourceEvidence summarized by the NIH applies to creatine research generally. It is not a clinical trial of TARRU gummies.
Health Canada maintains a creatine monohydrate monograph for natural health product licence applications and labels.
Health Canada’s June 28, 2024 creatine monohydrate monograph is a guide to industry for preparing product licence applications and labels. Its existence does not mean TARRU has been issued an NPN or market authorization.
Read Health Canada sourceResearch on creatine monohydrate can help explain the ingredient.
TARRU gummies have not been presented here as clinically tested.
Product-specific quantities and ingredient names come from the product or supplier specification.
TARRU’s launch product is Creatine Monohydrate Gummies in Natural Sour Blue Raspberry. The supplier specification lists 1,250 mg of creatine monohydrate per gummy and 120 gummies per container.
Research papers and official fact sheets often discuss specific study protocols. Those research doses should not be presented as TARRU usage directions unless they match the final approved product label.
Study populations, duration, exercise type, and dose can differ substantially.
TARRU product directions and warnings should come from the final production label.
People can respond differently to supplements; questions about personal use belong with a qualified health professional.
Yes. The NIH describes creatine as one of the most thoroughly studied dietary supplements for exercise and sports performance.
No. Ingredient-level research should not be represented as a clinical study of the finished TARRU gummy.
This page does not claim that TARRU has an NPN. Health Canada’s creatine monohydrate monograph is a regulatory reference for industry, not proof of a TARRU product licence.
The final production label should control product-specific directions and warnings. Research protocols are not automatically product directions.
Use the NIH and Health Canada links on this page to review the source material directly.